Novel technology to prepare oral formulations for preclinical safety studies.
A novel method to prepare oral formulations, normally suspended dosage form, for preclinical safety studies in animals has been developed using a rotation/revolution mixer. Small hard balls made of zirconia were added to the mixing process to evaluate effectiveness in making a high quality suspension. The driving with balls loaded in the cylindrical container (vessel) of the mixer was quite efficient in dispersing and milling the particles of the active pharmaceutical ingredient (API) in an aqueous medium. The API powder and a small amount of oral aqueous medium (vehicle) were successfully mixed by the spinning motion of the balls in the vessel as though the paste-like suspension was kneaded with a mortar and pestle. It was found that the milled suspension with the mean size of 10-20microm could be prepared, in addition finer milling of less than 10microm could be achieved by selecting the material of vessel. Optimum driving conditions including mixing time, size and quantity of balls, and the standard operational procedure was established using compounds varying in physicochemical properties. The particle size and quantitative analysis by HPLC showed that the resultant suspension was well-milled and highly homogeneous with the nearly intended concentration of API. The proposed method established by this experiment could be applied to the actual safety studies in the real preparation scale of oral suspension.
Niwa
Toshiyuki
T
Pharmaceutical Sciences, Nagoya Laboratories, Pfizer Global Research & Development, Chita, Aichi 470-2393, Japan. niwa-t@taiyo-yakuhin.co.jp
Hashimoto
Naofumi
N
D000284:Administration, Oral; D002626:Chemistry, Pharmaceutical; D004353:Drug Evaluation, Preclinical; D010316:Particle Size; D012399:Rotation; D013535:Suspensions; D013678:Technology, Pharmaceutical
D013535:Suspensions